FY2021
DFS and funding path
The Finniss DFS and updated Ore Reserve supported project planning; major equity funding was raised after 30 June 2021.
ASX: CXO · Five-year financial review
Core Lithium Ltd (ASX: CXO) - Five-Year Financial Review FY2021-FY2025
A$ thousands unless a row says otherwise. Current-year statutory figures are shown for each fiscal year; whole-dollar FY2021-FY2022 statements are scaled to A$ thousands. Project-study estimates and geological Resource/Reserve snapshots are identified separately.
Reading the tables: 0 (nil) is a supported zero. Other text distinguishes an amount included in another line, a non-applicable item, a separately unavailable component and an unresolved value. These are not interchangeable. Period-specific detail is labelled; complete year-by-year detail remains available.
FY2025 cash
A$23.486m
At 30 June 2025
FY2025 net loss
A$23.370m
Statutory result
FY2024 impairment
A$119.647m
Non-financial assets
Five years in context
The period spans Finniss project funding and construction, first production and revenue in FY2023, a price-led operating pause in FY2024, and care and maintenance in FY2025.
The FY2024 impairment and contract provision dominate the statutory loss. FY2025 has no product sales but retains quotation-period adjustments and a provision release. Cash flow also reflects the settlement of earlier customer advances.
Events behind the numbers
FY2022
Finniss construction
The final investment decision was announced on 30 September 2021 and mobilisation began in October 2021.
FY2023
First concentrate and revenue
The mine opened on 10 October 2022; first concentrate followed in February 2023 and the group reported its first revenue.
FY2024
Operating pause and impairment
Grants mining paused in January 2024 and DMS stockpile processing ceased in June; the annual result includes an A$119.647m non-financial asset impairment.
FY2025
Care and maintenance; restart study
Finniss remained in asset preservation. A May 2025 Restart Study set out a potential 20-year mine life; it is not a realised operating result.
FINANCIAL REVIEW / 01
Earnings and per-share results
Core moved from construction to first revenue in FY2023. The FY2024 result includes a major Finniss impairment and onerous contract charge; FY2025 records a provision release while sales remained nil.
The FY2021 and FY2022 annual reports state that no dividends were paid or declared in those reporting periods.
Annual net result
A$'000
Net profit / (loss)
AI-generated presentation · values from Consolidated profit or loss; no missing values plotted as zero.
Consolidated profit or loss
A$'000
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Reported revenue: FY2023-FY2024 net presentation; FY2025 gross product sales | — | — | 50,598 | 189,494 | nil |
| Quotation-period adjustments | — | — | Included in combined line | Included in combined line | (2,421) |
| Gross product sales before QP (comparable disclosure) | Not separately presented | Not separately presented | 52,236 | 239,998 | 0 (nil) |
| Net product revenue after QP (comparable) | Not separately presented | Not separately presented | 50,598 | 189,494 | (2,421) |
| Cost of sales | — | — | (19,653) | (200,256) | nil |
| Gross profit / (loss) | — | — | 30,945 | (10,762) | (2,421) |
| Interest income | 66.3 | 358.4 | 3,036 | 4,350 | 1,264 |
| Grant / other income | 249.0 | nil | 0 (nil) | 800 | 245 |
| Employee benefits expense | (1,110.8) | (3,453.4) | — | — | — |
| Exploration and evaluation expense | (91.6) | (27.2) | — | — | — |
| Operating expense | — | — | (6,599) | (23,064) | (18,447) |
| Royalties refund / (expense), separately presented | — | — | — | — | 1,981 |
| General and administration / other expense | (1,571.2) | (4,068.4) | (14,391) | (25,408) | (14,577) |
| Onerous contract expense / (release) | — | — | — | (25,270) | 12,761 |
| Impairment of non-financial assets | — | — | — | (119,647) | nil |
| Impairment of capitalised exploration | nil | 0 (nil) | (1,616) | (801) | nil |
| Inventory net realisable value movement | — | — | — | — | (2,568) |
| Finance costs | — | — | (2,269) | (2,655) | (1,945) |
| Foreign currency gain | — | — | 122 | 306 | 336 |
| Profit / (loss) before tax | (2,912.3) | (7,465.7) | 9,228 | (202,151) | (23,370) |
| Income tax benefit / (expense) | nil | nil | 1,582 | (4,862) | nil |
| Net profit / (loss) | (2,912.3) | (7,465.7) | 10,810 | (207,013) | (23,370) |
| Other comprehensive income / (loss) | nil | nil | nil | nil | (278) |
| Total comprehensive profit / (loss) | (2,912.3) | (7,465.7) | 10,810 | (207,013) | (23,647) |
A$ thousands. FY2021-FY2022 annual statements printed whole dollars and are divided by 1,000 here; one decimal is retained for those years.
Current-year statutory rows are used for each year. The original revenue row mixes FY2023–FY2024 net presentation with FY2025 gross presentation. FY2024 Note 14 separately reports gross product sales and QP adjustments for FY2023 and FY2024; the added gross and net comparable rows align FY2023–FY2025 without altering the original values. FY2023/FY2024 QP component cells are included in their net revenue cells, not additive expense rows; FY2025 gross sales are nil and separate prior-sales QP is (2,421).
The FY2025 royalties refund of 1,981 and FY2023-FY2025 FX gains are separately reported profit-or-loss components. Earlier-period blank royalty cells mean no separately selected comparable line.
Expense categories changed with first production; blank cells mean no separate comparable line in the selected current-year statement, not zero.
Basis and presentation notes (44)
- Reported revenue: FY2023-FY2024 net presentation; FY2025 gross product sales / FY2021 — —: Not separately presented in selected annual evidence
- Reported revenue: FY2023-FY2024 net presentation; FY2025 gross product sales / FY2022 — —: Not separately presented in selected annual evidence
- Reported revenue: FY2023-FY2024 net presentation; FY2025 gross product sales / FY2025 — nil: FY2025 nil gross product sales before separate QP adjustment.
- Quotation-period adjustments / FY2021 — —: Not separately presented in selected annual evidence
- Quotation-period adjustments / FY2022 — —: Not separately presented in selected annual evidence
- Quotation-period adjustments / FY2023 — Included in combined line: FY2024 Note 14 comparative discloses (A$1,638k) QP already included in FY2023 net revenue; not additional expense.
- Quotation-period adjustments / FY2024 — Included in combined line: FY2024 Note 14 discloses (A$50,504k) QP already included in original FY2024 net revenue; not additional expense.
- Gross product sales before QP (comparable disclosure) / FY2021 — Not separately presented: No commercial product-revenue line in selected pre-production statement; no zero inferred.
- Gross product sales before QP (comparable disclosure) / FY2022 — Not separately presented: No commercial product-revenue line in selected pre-production statement; no zero inferred.
- Gross product sales before QP (comparable disclosure) / FY2025 — 0 (nil): FY2025 no product sales before QP adjustment.
- Net product revenue after QP (comparable) / FY2021 — Not separately presented: No commercial product-revenue line in selected pre-production statement; no zero inferred.
- Net product revenue after QP (comparable) / FY2022 — Not separately presented: No commercial product-revenue line in selected pre-production statement; no zero inferred.
- Cost of sales / FY2021 — —: Not separately presented in selected annual evidence
- Cost of sales / FY2022 — —: Not separately presented in selected annual evidence
- Gross profit / (loss) / FY2021 — —: Not separately presented in selected annual evidence
- Gross profit / (loss) / FY2022 — —: Not separately presented in selected annual evidence
- Grant / other income / FY2023 — 0 (nil): FY2024 statutory profit-or-loss comparative reports FY2023 Other Income as nil.
- Employee benefits expense / FY2023 — —: Not separately presented in selected annual evidence
- Employee benefits expense / FY2024 — —: Not separately presented in selected annual evidence
- Employee benefits expense / FY2025 — —: Not separately presented in selected annual evidence
- Exploration and evaluation expense / FY2023 — —: Not separately presented in selected annual evidence
- Exploration and evaluation expense / FY2024 — —: Not separately presented in selected annual evidence
- Exploration and evaluation expense / FY2025 — —: Not separately presented in selected annual evidence
- Operating expense / FY2021 — —: Not separately presented in selected annual evidence
- Operating expense / FY2022 — —: Not separately presented in selected annual evidence
- Royalties refund / (expense), separately presented / FY2021 — —: Not separately presented in selected annual evidence
- Royalties refund / (expense), separately presented / FY2022 — —: Not separately presented in selected annual evidence
- Royalties refund / (expense), separately presented / FY2023 — —: Not separately presented in selected annual evidence
- Royalties refund / (expense), separately presented / FY2024 — —: Not separately presented in selected annual evidence
- Onerous contract expense / (release) / FY2021 — —: Not separately presented in selected annual evidence
- Onerous contract expense / (release) / FY2022 — —: Not separately presented in selected annual evidence
- Onerous contract expense / (release) / FY2023 — —: Not separately presented in selected annual evidence
- Impairment of non-financial assets / FY2021 — —: Not separately presented in selected annual evidence
- Impairment of non-financial assets / FY2022 — —: Not separately presented in selected annual evidence
- Impairment of non-financial assets / FY2023 — —: Not separately presented in selected annual evidence
- Impairment of capitalised exploration / FY2022 — 0 (nil): FY2023 statutory profit-or-loss comparative reports FY2022 capitalised-exploration impairment as nil.
- Inventory net realisable value movement / FY2021 — —: Not separately presented in selected annual evidence
- Inventory net realisable value movement / FY2022 — —: Not separately presented in selected annual evidence
- Inventory net realisable value movement / FY2023 — —: Not separately presented in selected annual evidence
- Inventory net realisable value movement / FY2024 — —: Not separately presented in selected annual evidence
- Finance costs / FY2021 — —: Not separately presented in selected annual evidence
- Finance costs / FY2022 — —: Not separately presented in selected annual evidence
- Foreign currency gain / FY2021 — —: Not separately presented in selected annual evidence
- Foreign currency gain / FY2022 — —: Not separately presented in selected annual evidence
Source: Core Lithium annual reports, selected current-year statement rows
Per-share measures and capital base
Mixed units; each row labelled
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Basic earnings / (loss) per sharecents per share | (0.27) | (0.47) | 0.59 | (9.88) | (1.10) |
| Diluted earnings / (loss) per sharecents per share | (0.27) | (0.47) | 0.59 | (9.88) | (1.10) |
| Weighted average basic sharesmillion shares | 1,060.2 | 1,580.0 | 1,818.7 | 2,095.0 | 2,141.7 |
| Issued ordinary shares at year endmillion shares | 1,174.1 | 1,732.6 | 1,858.5 | 2,136.9 | — |
EPS is in cents per share; share counts are millions. The two measures are not charted together.
Basis and presentation notes (1)
- Issued ordinary shares at year end / FY2025 — —: Not separately presented in selected annual evidence
Source: Core Lithium annual reports, selected current-year statement rows
FINANCIAL REVIEW / 02
Assets, obligations and equity
The Finniss build raised the carrying value of mine assets through FY2023. The FY2024 impairment reduced the balance; FY2025 cash fell further during care and maintenance.
Year-end cash
A$'000
Cash and cash equivalents
AI-generated presentation · values from Consolidated financial position at 30 June; no missing values plotted as zero.
Consolidated financial position at 30 June
A$'000
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 38,107.6 | 135,197.6 | 152,786 | 87,606 | 23,486 |
| Trade / other receivables | 115.0 | 2,554.7 | 6,745 | 1,460 | 1,121 |
| Current inventories | nil | 176.6 | 28,851 | 8,533 | 5,462 |
| Total current assets | 38,376.1 | 138,657.3 | 191,733 | 99,506 | 32,260 |
| Non-current inventories | — | — | 0 (nil) | 2,708 | 4,013 |
| Exploration and evaluation assets | 33,718.8 | 40,153.8 | 53,572 | 77,945 | 85,286 |
| Plant, equipment and mine development assets | 306.0 | 70,528.5 | 241,174 | 131,877 | 134,888 |
| Total non-current assets | 34,817.8 | 123,195.9 | 311,410 | 224,452 | 236,174 |
| Total assets | 73,193.9 | 261,853.2 | 503,143 | 323,958 | 268,434 |
| Trade and other payables | 1,575.9 | 14,038.7 | 30,978 | 16,623 | 3,746 |
| Financial liabilities | — | 0 (nil) | 83,623 | 661 | 9,500 |
| Current lease liabilities | 57.4 | 1,189.4 | 3,461 | 477 | 484 |
| Current provisions | 136.1 | 690.3 | 569 | 19,123 | 6,378 |
| Total current liabilities | 1,769.4 | 18,286.7 | 120,999 | 37,802 | 20,108 |
| Non-current lease liabilities | 44.9 | 896.8 | 19,483 | 3,057 | 2,427 |
| Non-current provisions | 65.1 | 3,944.9 | 7,739 | 26,227 | 11,621 |
| Total non-current liabilities | 110.0 | 4,841.8 | 27,222 | 29,284 | 14,048 |
| Total liabilities | 1,879.4 | 23,128.5 | 148,221 | 67,086 | 34,156 |
| Total equity | 71,314.5 | 238,724.8 | 354,922 | 256,872 | 234,279 |
| Issued capital | 90,606.9 | 265,668.4 | 370,940 | 478,632 | 479,240 |
| Accumulated losses | (19,945.0) | (27,397.5) | (16,550) | (223,380) | (246,310) |
A$ thousands. FY2021-FY2022 annual statements printed whole dollars and are divided by 1,000 here.
Financial liabilities include the customer prepayment in FY2023 and the FY2025 current settlement obligation; they are not labelled bank borrowings.
The FY2025 balance sheet is from the selected annual statement table and its saved row interpretations. It reports A$234.279m total equity.
FY2021 cash per the statement of cash flows includes A$80.25 thousand of term deposits, whereas balance-sheet cash is A$38.107642m.
Basis and presentation notes (5)
- Non-current inventories / FY2021 — —: Not separately presented in selected annual evidence
- Non-current inventories / FY2022 — —: Not separately presented in selected annual evidence
- Non-current inventories / FY2023 — 0 (nil): FY2024 statutory non-current inventory subtotal comparative explicitly reports nil at 30 June 2023.
- Financial liabilities / FY2021 — —: Not separately presented in selected annual evidence
- Financial liabilities / FY2022 — 0 (nil): FY2023 statement comparative explicitly reports nil current financial liabilities at 30 June 2022; not a claim about all financial liabilities.
Source: Core Lithium annual reports, selected current-year statement rows
FINANCIAL REVIEW / 03
Operating, investing and financing cash flows
The FY2023 operating inflow includes customer advances. Construction and mine development spending was concentrated in FY2022–FY2024. FY2025 operating and investing outflows reduced cash during suspended production.
Operating and investing cash flow
A$'000
Net operating cash flowNet investing cash flow
AI-generated presentation · values from Consolidated cash flows; no missing values plotted as zero.
Consolidated cash flows
A$'000
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Customer cash per original current-year statement (FY2024 net of repayments) | — | — | 134,704 | 108,639 | — |
| Gross customer receipts (FY2024 later comparative; FY2025 current) | — | — | — | 179,294 | 468 |
| Repayments to customers (FY2024 later comparative; FY2025 current) | — | — | — | (70,655) | (3,496) |
| Net customer cash receipts after repayments (comparable) | Not separately presented | Not separately presented | 134,704 | 108,639 | (3,028) |
| Payments to suppliers and employees | (2,658.4) | (6,578.1) | (45,842) | (190,166) | (42,123) |
| Net operating cash flow | (2,343.1) | (6,219.7) | 90,806 | (77,939) | (43,934) |
| Payments for plant, equipment and mine development | (140.7) | (51,391.8) | (150,614) | (60,648) | (11,781) |
| Payments for capitalised exploration | (7,859.6) | (17,826.6) | (14,995) | (26,583) | (7,628) |
| Payments for environmental / security bonds | (374.5) | (3,720.6) | (7,258) | (530) | 0 |
| Royalty sale proceeds | nil | 0 (nil) | 1,250 | nil | — |
| Government co-funding grants received (investing) | 0 (nil) | 2,490.8 | nil | 0 (nil) | 209 |
| Government co-funding grants repaid (investing) | — | — | 0 (nil) | (918) | (918) |
| Net investing cash flow | (8,374.7) | (70,558.0) | (171,617) | (88,637) | (19,853) |
| Proceeds from share issue | 41,563.3 | 149,875.5 | 100,000 | 111,368 | 0 |
| Proceeds from option exercises | 1,213.5 | 31,655.3 | 5,464 | nil | — |
| Share issue costs paid | (2,455.0) | (6,813.6) | (3,812) | (3,675) | 0 |
| Payments of lease liabilities | (125.8) | (849.4) | (3,862) | (5,300) | (626) |
| Net financing cash flow | 40,195.9 | 173,867.7 | 97,790 | 102,393 | +626 (sign disputed) |
| Net change in cash before FX | 29,478.1 | 97,090.0 | 16,979 | (64,183) | (64,413) |
| FX movement on cash | — | — | 609 | (997) | 293 |
| Closing cash per cash-flow statement | 38,187.9 | 135,197.6 | 152,786 | 87,606 | 23,486 |
A$ thousands. FY2021-FY2022 whole-dollar lines are divided by 1,000. Original cash flow totals are used for each year.
FY2023 original receipts include revenue received in advance. FY2024 original net customer cash of 108,639 is retained; the FY2025 annual comparative disaggregates it into gross receipts of 179,294 and repayments of (70,655). The added comparable net-customer-cash row preserves FY2023/FY2024 original net amounts and derives FY2025 (3,028) from 468 receipts less 3,496 repayments. The gross/repayment component rows are not separately established for FY2023.
FY2025 selected table and packet transcribe net financing as +626, shown here with a disputed-sign flag. Its only financing component is a (626) lease payment and the reported net cash decrease reconciles with (626). The sign remains unresolved; do not use +626 as an unqualified trend.
Basis and presentation notes (21)
- Customer cash per original current-year statement (FY2024 net of repayments) / FY2021 — —: Not separately presented in selected annual evidence
- Customer cash per original current-year statement (FY2024 net of repayments) / FY2022 — —: Not separately presented in selected annual evidence
- Customer cash per original current-year statement (FY2024 net of repayments) / FY2025 — —: Not separately presented in selected annual evidence
- Gross customer receipts (FY2024 later comparative; FY2025 current) / FY2021 — —: Not separately presented in selected annual evidence
- Gross customer receipts (FY2024 later comparative; FY2025 current) / FY2022 — —: Not separately presented in selected annual evidence
- Gross customer receipts (FY2024 later comparative; FY2025 current) / FY2023 — —: Not separately presented in selected annual evidence
- Repayments to customers (FY2024 later comparative; FY2025 current) / FY2021 — —: Not separately presented in selected annual evidence
- Repayments to customers (FY2024 later comparative; FY2025 current) / FY2022 — —: Not separately presented in selected annual evidence
- Repayments to customers (FY2024 later comparative; FY2025 current) / FY2023 — —: Not separately presented in selected annual evidence
- Net customer cash receipts after repayments (comparable) / FY2021 — Not separately presented: No separate comparable customer-receipts line in selected pre-production cash-flow statement; no zero inferred.
- Net customer cash receipts after repayments (comparable) / FY2022 — Not separately presented: No separate comparable customer-receipts line in selected pre-production cash-flow statement; no zero inferred.
- Royalty sale proceeds / FY2022 — 0 (nil): FY2023 cash-flow comparative explicitly reports nil FY2022 proceeds from royalty sale.
- Royalty sale proceeds / FY2025 — —: Not separately presented in selected annual evidence
- Government co-funding grants received (investing) / FY2021 — 0 (nil): FY2022 cash-flow comparative explicitly reports nil FY2021 investing grant receipts.
- Government co-funding grants received (investing) / FY2024 — 0 (nil): FY2025 cash-flow comparative explicitly reports nil FY2024 investing grant receipts.
- Government co-funding grants repaid (investing) / FY2021 — —: Not separately presented in selected annual evidence
- Government co-funding grants repaid (investing) / FY2022 — —: Not separately presented in selected annual evidence
- Government co-funding grants repaid (investing) / FY2023 — 0 (nil): FY2024 cash-flow comparative explicitly reports nil FY2023 investing grant repayments.
- Proceeds from option exercises / FY2025 — —: Not separately presented in selected annual evidence
- FX movement on cash / FY2021 — —: Not separately presented in selected annual evidence
- FX movement on cash / FY2022 — —: Not separately presented in selected annual evidence
Source: Core Lithium FY2021–FY2025 cash-flow statements; FY2025 selected annual table also inspected
FINANCIAL REVIEW / 04
Operating measures and project evidence
Finniss reached first concentrate output in FY2023, then mining at Grants was paused in January 2024 and DMS stockpile processing stopped in June 2024. The May 2025 Restart Study is a scenario for potential future operations.
Finniss production and sales during operating years
Mixed physical and price units; each row labelled
| Metric | FY2023 | FY2024 |
|---|---|---|
| Spodumene concentrate producedtonnes | 18,274 | 95,020 |
| Spodumene concentrate soldtonnes | 5,423 | 97,423 |
| Concentrate realised priceUS$/dry tonne | 4,163 | 1,574 |
| Lithium fines shippedwet tonnes | N/A | 66,140 |
| Lithium fines realised priceUS$/wet tonne | N/A | 103 |
| Issuer cash operating / C1 costA$/dry tonne | 1,155 | 1,396 |
FY2023 began first concentrate production; FY2024 saw the suspension of mining in January and stockpile processing in June.
FY2023 C1 cost and FY2024 cash operating cost are issuer measures with potentially different definitions; no cost trend chart is drawn.
Basis and presentation notes (2)
- Lithium fines shipped / FY2023 — N/A: Not applicable in FY2023: the first lithium fines shipment was in September 2023, after 30 June 2023.
- Lithium fines realised price / FY2023 — N/A: Not applicable in FY2023: the first lithium fines shipment was in September 2023, after 30 June 2023.
Source: Core Lithium annual reports, selected current-year statement rows
Finniss resources and reserves: dated disclosed estimates
Mixed geological units; each row labelled
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Mineral Resource, total tonnesMt | 14.72 | 18.86 | 30.54 | 48.20 | 48.20 |
| Mineral Resource grade% Li₂O | 1.32 | 1.32 | 1.31 | 1.26 | 1.26 |
| Mineral Resource contained Li₂Okt | 193.3 | 248.2 | 401.2 | 608.0 | 608.0 |
| Ore Reserve, total tonnesMt | 7.40 | 10.60 | 10.60 | 9.25 | 15.20 |
| Ore Reserve grade% Li₂O | 1.30 | 1.30 | 1.30 | 1.38 | 1.26 |
| Ore Reserve contained Li₂Okt | 97.9 | 143.0 | 141.8 | 127.6 | 192.0 |
Mineral Resources are not Ore Reserves. FY2021 uses the full-Finniss 14.72 Mt project total, not a narrower 2.89 Mt row in the same packet; its cut-off basis needs caution against the later 0.5% Li₂O figures.
FY2024 Ore Reserve is 9.25 Mt at 30 June 2024 in the original FY2024 Mineral Resource and Ore Reserves Statement, checked against the selected same-issuer annual table.
Ore Reserve scope changes across FY2024-FY2025: FY2024 9.25 Mt comprises Grants Open Pit and BP33 Underground; FY2025 15.2 Mt includes Grants, BP33, Carlton and TSF/Stockpiles. The two totals are not a like-for-like reserve increase.
FY2022–FY2025 resource estimates use the disclosed 0.5% Li₂O cut-off. FY2025 48.2 Mt in situ excludes the separately disclosed TSF/rejects addition.
Source: Core Lithium annual reports, selected current-year statement rows
May 2025 Restart Study assumptions (project case)
Mixed study assumptions; each row labelled
| Metric | May 2025 study |
|---|---|
| Life of mineyears | 20 |
| Annual throughputktpa | 1,200 |
| Average feed grade% Li₂O | 1.27 |
| Global recovery% | 78 |
| Nameplate concentrate output (SC6 equivalent)ktpa | 205 |
| Mining unit costUS$/t mined | 63 - 72 |
| Processing and tailings unit costUS$/t processed | 40 - 46 |
| Unit operating cost (FOB SC6 equivalent, excluding royalties)US$/t | 690 - 785 |
| Pre-production capitalA$m (extraction interpretation; individual table row has $m only) | 175 - 200 |
These are study estimates for a potential restart, not realised FY2025 operating results.
Frozen extraction assigns USD to the three per-tonne operating cost ranges and AUD to pre-production capital. The individual capital table row prints $m without an explicit currency, so its A$ reading is qualified by the extraction interpretation.
Basis and presentation notes (4)
- Mining unit cost / May 2025 study — 63 - 72: Issuer study range; not a single plotted value
- Processing and tailings unit cost / May 2025 study — 40 - 46: Issuer study range; not a single plotted value
- Unit operating cost (FOB SC6 equivalent, excluding royalties) / May 2025 study — 690 - 785: Issuer study range; not a single plotted value
- Pre-production capital / May 2025 study — 175 - 200: Issuer study range; not a single plotted value
Source: Core Lithium annual reports, selected current-year statement rows
Reading the figures
- FY2025 financing cash-flow subtotal is transcribed as +626 A$000 but has an unresolved sign conflict with its (626) lease payment and cash bridge.
- FY2021 full-Finniss Mineral Resource and later 0.5% Li₂O estimates may not share the same cut-off basis.
- FY2024 and FY2025 Ore Reserve totals have changed deposit/stockpile scope and are not directly like for like.
- The Restart Study capital row prints $m without a currency; the frozen extraction assigns AUD, while operating unit cost rows are assigned USD.
Annual-report source registry
- Core Lithium 2021 Annual Report to ShareholdersYear ended 2021-06-30; annual report dated 2021-09-21
- Core Lithium 2022 Annual Report to ShareholdersYear ended 2022-06-30; annual report dated 2022-09-27
- Core Lithium 2023 Annual Report to ShareholdersYear ended 2023-06-30; annual report dated 2023-09-29
- Core Lithium 2024 Annual Report to ShareholdersYear ended 2024-06-30; annual report dated 2024-09-27
- Core Lithium 2025 Annual Report to ShareholdersYear ended 2025-06-30; annual report dated 2025-09-26
Prepared from the existing annual extraction datasets, supplemented only by selected same-company annual-report tables and saved row interpretations. No new raw-document extraction or web financial research was used for this test.
Sources, copyright and independence
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
AI-led method
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
Information notice
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.